This case involves a compounding pharmacy that allegedly used insulin syringes to fill in an anti-cancer drug used off-label to treat eye conditions, including macular degeneration. The syringes were lubricated with silicone oil and not designed to be used for eye injections. However, they were allegedly sold to ophthalmologists for the treatment of macular degeneration. The silicone oil contamination resulted in silicone oil deposit in the eyes. This caused vision interference for patients who took the medication, and many required corrective laser surgery or a vitrectomy.